Celldex Therapeutics, Inc.
CLDXNasdaqCIK 744218HealthcareFiscal year ends Dec 31
Reports and events: 261 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2016-02-2508:20 ET | 10-K/A | Annual report, amendedPeriod 2015-12-31 | 0001047469-16-010396 |
| 2016-02-2507:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-16-008122 |
| 2016-02-2316:39 ET | 8-K | 8.01 Other events | 0001104659-16-099219 |
| 2016-02-2310:13 ET | 10-K | Annual reportPeriod 2015-12-31 | 0001047469-16-010308 |
| 2015-11-0517:01 ET | 10-Q | Quarterly reportPeriod 2015-09-30 | 0001104659-15-076295 |
| 2015-11-0516:50 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-15-006067 |
| 2015-08-1016:10 ET | 10-Q | Quarterly reportPeriod 2015-06-30 | 0001104659-15-058233 |
| 2015-08-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-15-004515 |
| 2015-06-1111:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-15-044791 |
| 2015-04-2908:29 ET | 10-Q | Quarterly reportPeriod 2015-03-31 | 0001104659-15-031298 |
| 2015-04-2908:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-15-002279 |
| 2015-04-2309:56 ET | DEF 14A | Proxy statementPeriod 2015-06-10 | 0001047469-15-003819 |
| 2015-02-2606:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-15-014023 |
| 2015-02-2408:31 ET | 10-K | Annual reportPeriod 2014-12-31 | 0001047469-15-001081 |
| 2015-02-2407:45 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-15-013213 |
| 2014-12-1808:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-14-005945 |
| 2014-11-0616:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-14-077686 |
| 2014-11-0509:09 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001104659-14-076822 |
| 2014-11-0416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-14-005224 |
| 2014-10-2009:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-14-072365 |
| 2014-08-0709:01 ET | 10-Q | Quarterly reportPeriod 2014-06-30 | 0001104659-14-057922 |
| 2014-08-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-14-003761 |
| 2014-05-2909:53 ET | 8-K | 5.07 Shareholder vote results | 0001104659-14-042206 |
| 2014-05-1408:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-14-038370 |
| 2014-05-0108:50 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001104659-14-033059 |
| 2014-05-0108:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-14-002068 |
| 2014-04-0909:01 ET | DEF 14A | Proxy statementPeriod 2014-05-28 | 0001047469-14-003582 |
| 2014-04-0809:16 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-14-026295 |
| 2014-03-0311:36 ET | 10-K | Annual reportPeriod 2013-12-31 | 0001047469-14-001653 |
| 2014-03-0308:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-14-001050 |
| 2013-12-0507:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-13-088493 |
| 2013-11-2508:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-13-086729 |
| 2013-11-2506:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-13-086714 |
| 2013-11-0809:47 ET | 10-Q | Quarterly reportPeriod 2013-09-30 | 0001104659-13-082619 |
| 2013-11-0808:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-13-004514 |
| 2013-08-0610:03 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001104659-13-060226 |
| 2013-06-1308:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-13-048808 |
| 2013-05-2008:25 ET | 8-K | 1.02 Termination of a material agreement | 0001104659-13-043025 |
| 2013-05-0308:51 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001104659-13-036833 |
| 2013-05-0208:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-13-036266 |
| 2013-04-2308:17 ET | DEF 14A | Proxy statementPeriod 2013-06-12 | 0001047469-13-004692 |
| 2013-03-0812:53 ET | 10-K | Annual reportPeriod 2012-12-31 | 0001047469-13-002403 |
| 2013-03-0708:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-13-018165 |
| 2013-02-0606:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-13-007717 |
| 2013-02-0416:04 ET | 8-K | 8.01 Other events | 0001104659-13-007111 |
| 2013-01-0708:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-13-000878 |
| 2012-12-2108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-12-085680 |
| 2012-11-0208:14 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001104659-12-073441 |
| 2012-11-0108:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-12-005610 |
| 2012-09-2408:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-12-064917 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 19:04 ET. Listed shows no prices and gives no investment advice.